# Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen

> **NCT01524679** · PHASE2 · COMPLETED · sponsor: **Johannes Gutenberg University Mainz** · enrollment: 170 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Pegylated interferon alfa-2a plus nucleos(t)ide(s)

## Key facts

- **NCT ID:** NCT01524679
- **Lead sponsor:** Johannes Gutenberg University Mainz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2017-08-28
- **Final completion:** 2017-08-28
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2020-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01524679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01524679, "Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01524679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*